Scott Minick, longtime executive and board member of leading pharmaceutical and biotechnology companies, has been elected as the new Chair of the Board of Directors for California Pacific Medical Center.
A group of scientists at the Scripps Research Institute has identified a mechanism that enables certain compounds to activate a pain sensing protein. The findings could lead to the development of potential new therapies for managing acute and chronic pain.
The American Society for Aesthetic Plastic Surgery and the American Society of Plastic Surgeons issue patient safety advisory on Medi-spas.
A new study says early termination of the highly effective breast cancer drug tamoxifen may negatively affect treatment efficacy.
Patients with early stage oral cancer may benefit from a more advanced screening process allowing for a more accurate diagnosis, according to a study presented at the plenary session today at the Multidisciplinary Head and Neck Cancer Symposium in Rancho Mirage, Calif., co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society of Clinical Oncology and the American Head and Neck Society.
The Pharmaceutical Research and Manufacturers of America, through its Partnership for Prescription Assistance (PPA), is expanding its educational efforts today aimed at making uninsured Americans aware of programs that are available to help them better afford their prescription medicines and finding healthcare services in their community.
A hormone found naturally in the gut is the basis of a new drug to tackle obesity to be developed through one of three inaugural awards under the Wellcome Trust’s Seeding Drug Discovery initiative. The drug is being developed by one of the world’s leading obesity experts, Professor Steve Bloom at Imperial College London’s Hammersmith Hospital campus.
A team of researchers from the CIMA of the University of Navarra has discovered a possible cause of thrombosis, and has developed a new diagnostic test for this disease. The scientific project was undertaken in the Hemostasis and Thrombosis Laboratory.
Ghost authorship is the failure to name, as an author, an individual who has made a substantial contribution to a scientific article. A study of 44 industry-initiated trials from Denmark in the 1990s found evidence of ghost authorship for 33 trials, which increased to 40 if a person qualifying for authorship was just acknowledged rather than being named as an author.
Cloudy apple juice is better for you than clear varieties, say researchers. Polish scientists found the levels of antioxidants which protect against heart disease and cancer are almost double in cloudy apple juice. The study published in the Journal of the Science of Food and Agriculture.